Volitionrx (VNRX) Income from Continuing Operations (2012 - 2026)
Volitionrx's (VNRX) quarterly Income from Continuing Operations came in at 260595.0 in Q4 2025, down 49.54% YoY from 516444.0 in Q4 2024, and up 929.05% on a QoQ basis from 31433.0 in Q3 2025.
Volitionrx (VNRX) Income from Continuing Operations (2012 - 2026) Analysis & Trends
Volitionrx (VNRX) has 10 years of Income from Continuing Operations data on file, last reported at 260595.0 in Q4 2025.
- Quarterly Income from Continuing Operations fell 49.54% year-over-year to 260595.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 5677082.0 (up 31.64% YoY) and the FY2025 annual result came in at 146302.0, down 49.58% from the prior year.
- Income from Continuing Operations advanced to 260595.0 in Q4 2025, from 31433.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 516444.0 in Q4 2024 to a low of 10103412.0 in Q2 2023.
- A 5-year average of 2560071.05 and a median of 37528.5 in 2021 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations surged 791.1% — and 2023, when it slumped 13369.88%.
- Tracing VNRX's Income from Continuing Operations over 5 years: stood at 73088.0 in 2021, then advanced by 28.74% to 94092.0 in 2022, then plunged by 9442.17% to 8790236.0 in 2023, then surged by 105.88% to 516444.0 in 2024, then sank by 49.54% to 260595.0 in 2025.
- The last three Income from Continuing Operations figures came in at 260595.0 (Q4 2025), 31433.0 (Q3 2025), and 29992.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Volitionrx | 1.19 Mn | -1.60 Mn | - | -4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.90 Mn |
| Dec 31, 2025 | 260,595.00 |
| Sep 30, 2025 | -31,433.00 |
| Jun 30, 2025 | 29,992.00 |
| Mar 31, 2025 | -5.94 Mn |
| Dec 31, 2024 | 516,444.00 |
| Sep 30, 2024 | -47,049.00 |
| Jun 30, 2024 | 74,629.00 |
| Mar 31, 2024 | -8.85 Mn |
| Dec 31, 2023 | -8.79 Mn |
| Sep 30, 2023 | -9.20 Mn |
| Jun 30, 2023 | -10.10 Mn |
| Mar 31, 2023 | -9.63 Mn |
| Dec 31, 2022 | 94,092.00 |
| Sep 30, 2022 | 69,305.00 |
| Jun 30, 2022 | 82,302.00 |
| Mar 31, 2022 | 83,977.00 |
| Dec 31, 2021 | 73,088.00 |
| Sep 30, 2021 | 45,065.00 |
| Jun 30, 2021 | 47,539.00 |